Europe Cough Syrup Market 2023-2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	117 Pages	Triton Market Research	October, 2023	TRTN18369742

Best Price Guarantee
Price	from $1,500
Length	117 Pages
Publisher	Triton Market Research
Published Date	October, 2023
SKU	TRTN18369742

Europe Cough Syrup Market 2023-2030

Market Outlook

Triton Market Research’s report states that the Europe cough syrup market is projected to display a compound annual growth rate of 3.65% during 2023-2030. Germany, Italy, the United Kingdom, Spain, France, and the Rest of Europe are considered in the region.

The accessibility of codeine-containing cough syrups as an over-the-counter (OTC) medication is set to boost the expansion of the cough syrup market within France. This divergence in accessibility bestows French consumers an exceptional advantage, affording them increased convenience and independence in addressing their coughs and associated symptoms.

Further, the increasing demand for cough syrup in Spain can be attributed to various factors. One primary factor is the fluctuating weather conditions, which tend to pilot a rise in respiratory ailments like colds and the flu, resulting in a higher prevalence of coughing. In response to these symptoms, numerous people opt for cough syrups as a convenient and productive remedy, which significantly widens the market’s growth.

Competitive Outlook

The key companies listed in the cough syrup market consist of Sanofi SA, Novartis AG, Cipla Limited, AstraZeneca Plc, Reckitt Benckiser Group Plc, The Procter & Gamble Company, and Kenvue Inc.

1. Europe Cough Syrup Market - Summary
2. Industry Outlook: 2.1. Impact Analysis On The Cough Syrup Market; 2.1.1. Covid-19 Impact; 2.1.2. Ukraine-russia War Impact; 2.2. Porter’s Five Forces Analysis; 2.2.1. Threat Of New Entrants; 2.2.2. Threat Of Substitutes; 2.2.3. Bargaining Power Of Buyers; 2.2.4. Bargaining Power Of Suppliers; 2.2.5. Threat Of Competitive Rivalry; 2.3. Industry Components; 2.3.1. Raw Materials; 2.3.2. Manufacturers; 2.3.3. Distributors; 2.3.4. Retailers; 2.4. Regulatory Framework; 2.5. Key Market Strategies; 2.5.1. Collaborations; 2.5.2. Product Launches; 2.5.3. Acquisitions; 2.5.4. Business Divestitures & Expansions; 2.6. Market Drivers; 2.6.1. High Incidence Of Respiratory Ailments; 2.6.2. Vulnerability To Respiratory Diseases Among The Geriatric Population; 2.6.3. Innovations In Cough Syrups; 2.7. Market Challenges; 2.7.1. Overdose Risks Associated With Cough Syrups; 2.7.2. Strict Regulatory Requirements; 2.7.3. Increasing Cough Syrup Deaths Due To Toxic Ingredients; 2.8. Market Opportunities; 2.8.1. Self-medication Trends Increase Demand For Otc Drugs; 2.8.2. Herbal Cough Syrups Emerge As A Safer Alternative; 2.8.3. Ease Of Purchase Offered By E-commerce Channels; 2.8.4. Availability Of Sugar-free Cough Syrups; 2.8.5. Growing Preference For Homeopathic Cough Syrups; 2.9. Analyst Perspective
3. Europe Cough Syrup Market – By Product Type: 3.1. Cough Suppressants; 3.2. Combination Medicines; 3.3. Expectorants
4. Europe Cough Syrup Market – By Age Group: 4.1. Adults; 4.2. Adolescents; 4.3. Pediatric
5. Europe Cough Syrup Market – By Distribution Channel: 5.1. Retail Pharmacies; 5.2. Hospital Pharmacies; 5.3. E-pharmacies
6. Europe Cough Syrup Market – By Country Outlook: 6.1. United Kingdom; 6.1.1. United Kingdom Cough Syrup Market Forecast & Prospects; 6.2. Germany; 6.2.1. Germany Cough Syrup Market Forecast & Prospects; 6.3. France; 6.3.1. France Cough Syrup Market Forecast & Prospects; 6.4. Italy; 6.4.1. Italy Cough Syrup Market Forecast & Prospects; 6.5. Spain; 6.5.1. Spain Cough Syrup Market Forecast & Prospects; 6.6. Rest Of Europe; 6.6.1. Rest Of Europe Cough Syrup Market Forecast & Prospects
7. Competitive Landscape: 7.1. Gsk Plc; 7.1.1. Overview; 7.1.2. Product Portfolio; 7.1.3. Key Strengths; 7.1.4. Key Challenges; 7.2. Pfizer Inc; 7.2.1. Overview; 7.2.2. Product Portfolio; 7.2.3. Key Strengths; 7.2.4. Key Challenges; 7.3. Novartis Ag; 7.3.1. Overview; 7.3.2. Product Portfolio; 7.3.3. Key Strengths; 7.3.4. Key Challenges; 7.4. Reckitt Benckiser Group Plc; 7.4.1. Overview; 7.4.2. Product Portfolio; 7.4.3. Key Strengths; 7.4.4. Key Challenges; 7.5. The Procter & Gamble Company; 7.5.1. Overview; 7.5.2. Product Portfolio; 7.5.3. Key Strengths; 7.5.4. Key Challenges; 7.6. Sanofi Sa; 7.6.1. Overview; 7.6.2. Product Portfolio; 7.6.3. Key Strengths; 7.6.4. Key Challenges; 7.7. Cipla Limited; 7.7.1. Overview; 7.7.2. Product Portfolio; 7.7.3. Key Strengths; 7.7.4. Key Challenges; 7.8. Kenvue Inc; 7.8.1. Overview; 7.8.2. Product Portfolio; 7.8.3. Key Strengths; 7.8.4. Key Challenges; 7.9. Astrazeneca Plc; 7.9.1. Overview; 7.9.2. Product Portfolio; 7.9.3. Key Strengths; 7.9.4. Key Challenges; 7.10. Acella Pharmaceuticals; 7.10.1. Overview; 7.10.2. Product Portfolio; 7.10.3. Key Strengths; 7.10.4. Key Challenges; 7.11. The Himalaya Wellness Company; 7.11.1. Overview; 7.11.2. Product Portfolio; 7.11.3. Key Strengths; 7.11.4. Key Challenges; 7.12. Merck Kgaa; 7.12.1. Overview; 7.12.2. Product Portfolio; 7.12.3. Key Strengths; 7.12.4. Key Challenges; 7.13. Abbott Laboratories; 7.13.1. Overview; 7.13.2. Product Portfolio; 7.13.3. Key Strengths; 7.13.4. Key Challenges; 7.14. Glenmark Pharmaceuticals Limited; 7.14.1. Overview; 7.14.2. Product Portfolio; 7.14.3. Key Strengths; 7.14.4. Key Challenges; 7.15. Dabur India Ltd; 7.15.1. Overview; 7.15.2. Product Portfolio; 7.15.3. Key Strengths; 7.15.4. Key Challenges
8. Research Methodology & Scope: 8.1. Research Scope & Deliverables; 8.2. Sources Of Data; 8.3. Research Methodology
List Of Tables: Table 1: Europe Cough Syrup Market, By Country Outlook, 2023-2030 (In $ Million); Table 2: Regulatory Framework; Table 3: List Of Collaborations; Table 4: List Of Product Launches; Table 5: List Of Acquisitions; Table 6: List Of Business Divestitures & Expansions; Table 7: Europe Cough Syrup Market, By Product Type, 2023-2030 (In $ Million); Table 8: Europe Cough Syrup Market, By Age Group, 2023-2030 (In $ Million); Table 9: Europe Cough Syrup Market, By Distribution Channel, 2023-2030 (In $ Million); Table 10: Europe Cough Syrup Market, By Country Outlook, 2023-2030 (In $ Million)
List Of Figures: Figure 1: Industry Components; Figure 2: Europe Cough Syrup Market, By Product Type, 2022 & 2030 (In %); Figure 3: Europe Cough Syrup Market, By Cough Suppressants, 2023-2030 (In $ Million); Figure 4: Europe Cough Syrup Market, By Combination Medicines, 2023-2030 (In $ Million); Figure 5: Europe Cough Syrup Market, By Age Group, 2022 & 2030 (In %); Figure 6: Europe Cough Syrup Market, By Adults, 2023-2030 (In $ Million); Figure 7: Europe Cough Syrup Market, By Adolescents, 2023-2030 (In $ Million); Figure 8: Europe Cough Syrup Market, By Pediatric, 2023-2030 (In $ Million); Figure 9: Europe Cough Syrup Market, By Distribution Channel, 2022 & 2030 (In %); Figure 10: Europe Cough Syrup Market, By Retail Pharmacies, 2023-2030 (In $ Million); Figure 11: Europe Cough Syrup Market, By Hospital Pharmacies, 2023-2030 (In $ Million); Figure 12: Europe Cough Syrup Market, By E-pharmacies, 2023-2030 (In $ Million); Figure 13: Europe Cough Syrup Market, By Country Outlook, 2022 & 2030 (In %); Figure 14: United Kingdom Cough Syrup Market 2023-2030 (In $ Million); Figure 15: Germany Cough Syrup Market 2023-2030 (In $ Million); Figure 16: France Cough Syrup Market 2023-2030 (In $ Million); Figure 17: Italy Cough Syrup Market 2023-2030 (In $ Million); Figure 18: Spain Cough Syrup Market 2023-2030 (In $ Million); Figure 19: Rest Of Europe Cough Syrup Market 2023-2030 (In $ Million)